Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.
The Food and Drug Administration on Thursday approved an oral treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of medicine for the blood cancer and the first drug cleared by U.S. regulators using ... [586 chars]